Skandinaviska Enskilda Banken Ab (Publ) Regeneron Pharmaceuticals, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$19.9 Billion
Q1 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 68,140 shares of REGN stock, worth $33.4 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

68,140

Previous 68,328 0.28%

Holding current value

$33.4 Million

Previous $48.7 Million 11.21%

% of portfolio

0.22%

Previous 0.22%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$634.14 - $744.83 $119,218 - $140,028	-188 Reduced 0.28%	68,140 $43.2 Million
Q4 2024 Feb 10, 2025	SELL	$701.85 - $1046.91 $4.83 Million - $7.21 Million	-6,888 Reduced 9.16%	68,328 $48.7 Million
Q3 2024 Nov 07, 2024	BUY	$1024.09 - $1201.76 $1.44 Million - $1.69 Million	1,408 Added 1.91%	75,216 $79.1 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $128,947 - $156,393	-146 Reduced 0.2%	73,808 $77.6 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $1.78 Million - $1.96 Million	-1,973 Reduced 2.6%	73,954 $71.2 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $377,512 - $429,387	-487 Reduced 0.64%	75,927 $66.7 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $16.3 Million - $19.9 Million	-23,521 Reduced 23.54%	76,414 $62.9 Million
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $7.37 Million - $8.74 Million	10,522 Added 11.77%	99,935 $71.8 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $7.42 Million - $9.01 Million	-10,901 Reduced 10.87%	89,413 $73.5 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $17.6 Million - $19.1 Million	-24,893 Reduced 19.88%	100,314 $72.4 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $7.55 Million - $9.53 Million	13,161 Added 11.75%	125,207 $86.3 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $22.6 Million - $30.5 Million	-41,230 Reduced 26.9%	112,046 $66.2 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $27.6 Million - $32.4 Million	-46,354 Reduced 23.22%	153,276 $107 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $49.4 Million - $61 Million	90,971 Added 83.72%	199,630 $128 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $30.3 Million - $36 Million	52,821 Added 94.6%	108,659 $65.8 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $13.2 Million - $15.6 Million	-27,991 Reduced 33.39%	55,838 $31.2 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $14.3 Million - $17.6 Million	-32,058 Reduced 27.66%	83,829 $39.7 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $5.62 Million - $7.15 Million	11,759 Added 11.29%	115,887 $56 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $3.11 Million - $3.75 Million	5,703 Added 5.79%	104,128 $58.3 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $9.28 Million - $12.1 Million	-18,817 Reduced 16.05%	98,425 $61.4 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $9.85 Million - $14.5 Million	-29,290 Reduced 19.99%	117,242 $57.2 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $28.4 Million - $39 Million	103,589 Added 241.22%	146,532 $55 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $3.42 Million - $3.98 Million	-12,504 Reduced 22.55%	42,943 $11.9 Million
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $23 Million - $31.8 Million	-76,750 Reduced 58.06%	55,447 $17.4 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $463,239 - $547,264	1,245 Added 0.95%	132,197 $54.3 Million
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $11.9 Million - $14.2 Million	35,323 Added 36.94%	130,952 $48.9 Million
Q3 2018 Nov 05, 2018	BUY	$351.14 - $408.51 $18.2 Million - $21.2 Million	51,903 Added 118.7%	95,629 $38.6 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.14 Million - $1.38 Million	4,003 Added 10.08%	43,726 $15.1 Million
Q1 2018 Apr 30, 2018	SELL	$315.82 - $393.78 $950,302 - $1.18 Million	-3,009 Reduced 7.04%	39,723 $13.7 Million
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $701,838 - $919,692	-1,957 Reduced 4.38%	42,732 $16.1 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $905,898 - $1.06 Million	-2,100 Reduced 4.49%	44,689 $20 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,789	46,789 $0

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $52.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Regeneron Pharmaceuticals, Inc. Transaction History